결핵 진단 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 검사 유형별, 최종 용도별, 지역별, 경쟁별(2020-2030년)

The Global Tuberculosis Diagnostics Market, valued at USD 2.52 Billion in 2024, is projected to experience a CAGR of 6.37% to reach USD 3.65 Billion by 2030. The global tuberculosis diagnostics market develops and deploys tests and tools for identifying *Mycobacterium tuberculosis*, the causative agent of tuberculosis. Market expansion is driven by the significant global disease burden and the imperative for swift, precise detection. Technological advancements, particularly in molecular assays, alongside increasing governmental and organizational support for TB control, further stimulate growth.

Key Market Drivers

The advancements in diagnostic technologies significantly propel the global tuberculosis diagnostics market by enhancing the speed, accuracy, and accessibility of testing solutions. Innovations such as molecular diagnostics, artificial intelligence powered imaging, and next-generation sequencing are transforming the diagnostic landscape, enabling earlier detection and more effective disease management. These technological improvements are particularly crucial for identifying latent tuberculosis infection and for deployment in diverse healthcare settings, from central laboratories to point-of-care environments. For instance, according to a Pharmacy Times news report, in April 2025, the FDA approved the Auto-Pure 2400 liquid handling platform with the T-SPOT. TB test, which allows laboratories to process up to 24 samples in under 3.5 hours for faster and more accurate latent TB diagnosis.

Key Market Challenges

Ensuring affordable and accessible advanced diagnostic technologies in resource-limited regions presents a significant impediment to the expansion of the Global Tuberculosis Diagnostics Market. The high capital expenditure required for advanced molecular diagnostic platforms, coupled with the recurring costs of reagents and consumables, creates substantial financial barriers for public health systems in high-burden, low-income countries. This economic constraint often leads to the underutilization or non-adoption of advanced diagnostic tools despite their accuracy and speed.

Key Market Trends

The rise in automated diagnostic platforms significantly drives the global tuberculosis diagnostics market by enhancing testing throughput and operational efficiency. These systems streamline laboratory workflows, minimizing manual intervention and accelerating sample processing, thereby reducing turnaround times for results. By the end of 2023, the Stop TB Partnership reported that cumulative global procurement of GeneXpert machines, representing key automated molecular platforms, exceeded 16,000 units across 167 countries, demonstrating substantial integration into diagnostic infrastructure. This increased capacity is crucial for managing high sample volumes in high-burden settings.

Key Market Players

• Abbott Laboratories Inc.
• Becton, Dickinson, and Company
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• BioMerieux SA
• Hain Lifescience GmbH
• QIAGEN NV
• Cepheid
• Hologic, Inc.

Report Scope:

In this report, the Global Tuberculosis Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Tuberculosis Diagnostics Market, By Test Type:

• Radiographic Method
• Diagnostic Laboratory Methods
• Nucleic Acid Testing
• Phage Assay
• Detection of Latent Infection
• Cytokine Detection Assay
• Detection of Drug Resistance (DST)
• Others

Tuberculosis Diagnostics Market, By End-Use:

• Diagnostic Laboratories
• Hospitals & Clinics
• Others

Tuberculosis Diagnostics Market, By Region:

• North America
• Europe
• Asia-Pacific
• South America
• MEA

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Tuberculosis Diagnostics Market.

Available Customizations:

Global Tuberculosis Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Tuberculosis Diagnostics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Test Type (Radiographic Method, Diagnostic Laboratory Methods, Nucleic Acid Testing, Phage Assay, Detection of Latent Infection, Cytokine Detection Assay, Detection of Drug Resistance (DST), others)
  • 5.2.2. By End-Use (Diagnostic Laboratories, Hospitals & Clinics, others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Tuberculosis Diagnostics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Test Type
  • 6.2.2. By End-Use
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Tuberculosis Diagnostics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Test Type
      • 6.3.1.2.2. By End-Use
  • 6.3.2. Canada Tuberculosis Diagnostics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Test Type
      • 6.3.2.2.2. By End-Use
  • 6.3.3. Mexico Tuberculosis Diagnostics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Test Type
      • 6.3.3.2.2. By End-Use

7. Europe Tuberculosis Diagnostics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Test Type
  • 7.2.2. By End-Use
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Tuberculosis Diagnostics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Test Type
      • 7.3.1.2.2. By End-Use
  • 7.3.2. France Tuberculosis Diagnostics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Test Type
      • 7.3.2.2.2. By End-Use
  • 7.3.3. United Kingdom Tuberculosis Diagnostics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Test Type
      • 7.3.3.2.2. By End-Use
  • 7.3.4. Italy Tuberculosis Diagnostics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Test Type
      • 7.3.4.2.2. By End-Use
  • 7.3.5. Spain Tuberculosis Diagnostics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Test Type
      • 7.3.5.2.2. By End-Use

8. Asia Pacific Tuberculosis Diagnostics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Test Type
  • 8.2.2. By End-Use
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Tuberculosis Diagnostics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Test Type
      • 8.3.1.2.2. By End-Use
  • 8.3.2. India Tuberculosis Diagnostics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Test Type
      • 8.3.2.2.2. By End-Use
  • 8.3.3. Japan Tuberculosis Diagnostics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Test Type
      • 8.3.3.2.2. By End-Use
  • 8.3.4. South Korea Tuberculosis Diagnostics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Test Type
      • 8.3.4.2.2. By End-Use
  • 8.3.5. Australia Tuberculosis Diagnostics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Test Type
      • 8.3.5.2.2. By End-Use

9. Middle East & Africa Tuberculosis Diagnostics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Test Type
  • 9.2.2. By End-Use
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Tuberculosis Diagnostics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Test Type
      • 9.3.1.2.2. By End-Use
  • 9.3.2. UAE Tuberculosis Diagnostics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Test Type
      • 9.3.2.2.2. By End-Use
  • 9.3.3. South Africa Tuberculosis Diagnostics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Test Type
      • 9.3.3.2.2. By End-Use

10. South America Tuberculosis Diagnostics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Test Type
  • 10.2.2. By End-Use
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Tuberculosis Diagnostics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Test Type
      • 10.3.1.2.2. By End-Use
  • 10.3.2. Colombia Tuberculosis Diagnostics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Test Type
      • 10.3.2.2.2. By End-Use
  • 10.3.3. Argentina Tuberculosis Diagnostics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Test Type
      • 10.3.3.2.2. By End-Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Tuberculosis Diagnostics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Abbott Laboratories Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Becton, Dickinson, and Company
• 15.3. F. Hoffmann-La Roche Ltd.
• 15.4. Thermo Fisher Scientific Inc.
• 15.5. BioMerieux SA
• 15.6. Hain Lifescience GmbH
• 15.7. QIAGEN NV
• 15.8. Cepheid
• 15.9. Hologic, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer